1-10 of 10
immunity
Close
Sort by
Journal Articles

The GPCR adaptor protein norbin suppresses the neutrophil-mediated immunity of mice to pneumococcal infection

Chiara Pantarelli, Dingxin Pan, Stephen Chetwynd, Anne-Katrien Stark, Kirsti Hornigold, Polly Machin, Laraine Crossland, Simon J. Cleary, Martin J. Baker, Elizabeth Hampson, Anna Mandel, Anne Segonds-Pichon, Rachael Walker, Cornelis van ’t Veer, Yanira Riffo-Vasquez, Klaus Okkenhaug, Simon Pitchford, Heidi C.E. Welch
Journal: Blood Advances
Blood Adv (2021) 5 (16): 3076–3091.
https://doi.org/10.1182/bloodadvances.2020002782
Published: 2021
Includes: Supplemental data
Journal Articles

Activity of blinatumomab in lymphoblastic leukemia with impaired T-cell immunity due to congenital immunodeficiency

Clinical Trials & Observations
Sandheeah Ramdeny, Asima Chaudhary, Austen Worth, Sara Ghorashian, Mary Slatter, Su Han Lum, Ajay Vora
Journal: Blood Advances
Blood Adv (2021) 5 (8): 2153–2155.
https://doi.org/10.1182/bloodadvances.2021004284
Published: 2021
Journal Articles

Tandem high-dose influenza vaccination is associated with more durable serologic immunity in patients with plasma cell dyscrasias

Clinical Trials & Observations
Andrew R. Branagan, Eamon Duffy, Geliang Gan, Fangyong Li, Connor Foster, Rakesh Verma, Lin Zhang, Terri L. Parker, Stuart Seropian, Dennis L. Cooper, Debra Brandt, Jeremy Kortmansky, Davit Witt, Thomas M. Ferencz, Kavita M. Dhodapkar, Madhav V. Dhodapkar
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1535–1539.
https://doi.org/10.1182/bloodadvances.2020003880
Published: 2021
Includes: Supplemental data
Journal Articles

Platelet-targeted hyperfunctional FIX gene therapy for hemophilia B mice even with preexisting anti-FIX immunity

Jocelyn A. Schroeder, Juan Chen, Yingyu Chen, Yuanhua Cai, Hongyin Yu, Jeremy G. Mattson, Paul E. Monahan, Qizhen Shi
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1224–1238.
https://doi.org/10.1182/bloodadvances.2020004071
Published: 2021
Includes: Supplemental data
Journal Articles

Enhancing antitumor immunity through checkpoint blockade as a therapeutic strategy in T-cell lymphomas

Alexander Neuwelt, Taha Al-Juhaishi, Eduardo Davila, Bradley Haverkos
Journal: Blood Advances
Blood Adv (2020) 4 (17): 4256–4266.
https://doi.org/10.1182/bloodadvances.2020001966
Published: 2020
Journal Articles

The critical role of CD4 + T cells in PD-1 blockade against MHC-II–expressing tumors such as classic Hodgkin lymphoma

Joji Nagasaki, Yosuke Togashi, Takeaki Sugawara, Makiko Itami, Nobuhiko Yamauchi, Junichiro Yuda, Masato Sugano, Yuuki Ohara, Yosuke Minami, Hirohisa Nakamae, Masayuki Hino, Masahiro Takeuchi, Hiroyoshi Nishikawa
Journal: Blood Advances
Blood Adv (2020) 4 (17): 4069–4082.
https://doi.org/10.1182/bloodadvances.2020002098
Published: 2020
Includes: Supplemental data
Journal Articles

Reduced-intensity single-unit unrelated cord blood transplant with optional immune boost for nonmalignant disorders

Clinical Trials & Observations
Mark T. Vander Lugt, Xiaohua Chen, Maria L. Escolar, Beth A. Carella, Jessie L. Barnum, Randy M. Windreich, Memphis J. Hill, Michelle Poe, Rebecca A. Marsh, Heather Stanczak, Elizabeth O. Stenger, Paul Szabolcs
Journal: Blood Advances
Blood Adv (2020) 4 (13): 3041–3052.
https://doi.org/10.1182/bloodadvances.2020001940
Published: 2020
Includes: Supplemental data
Journal Articles

Dimorphism in the TCRγ-chain repertoire defines 2 types of human immunity to Epstein-Barr virus

Zakia Djaoud, Peter Parham
Journal: Blood Advances
Blood Adv (2020) 4 (7): 1198–1205.
https://doi.org/10.1182/bloodadvances.2019001179
Published: 2020
Journal Articles

Kinetics of immune cell reconstitution predict survival in allogeneic bone marrow and G-CSF–mobilized stem cell transplantation

Clinical Trials & Observations
Edmund K. Waller, Brent R. Logan, Mingwei Fei, Stephanie J. Lee, Dennis Confer, Alan Howard, Shanmuganathan Chandrakasan, Claudio Anasetti, Shanelle M. Fernando, Cynthia R. Giver
Journal: Blood Advances
Blood Adv (2019) 3 (15): 2250–2263.
https://doi.org/10.1182/bloodadvances.2018029892
Published: 2019
Includes: Supplemental data
Journal Articles

Clinical consequences of clonal hematopoiesis of indeterminate potential

David P. Steensma
Journal: Blood Advances
Blood Adv (2018) 2 (22): 3404–3410.
https://doi.org/10.1182/bloodadvances.2018020222
Published: 2018